Latest Insider Transactions at Marchex Inc (MCHX)
This section provides a real-time view of insider transactions for Marchex Inc (MCHX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARCHEX INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARCHEX INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2022
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.01%
|
$125
$1.95 P/Share
|
|
May 24
2022
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.01%
|
$125
$1.9 P/Share
|
|
May 19
2022
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.01%
|
$250
$2.2 P/Share
|
|
May 17
2022
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.01%
|
$250
$2.13 P/Share
|
|
Jan 03
2022
|
Ryan Polley Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.41%
|
$0
$0.01 P/Share
|
|
Jan 03
2022
|
John Roswech Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.76%
|
$0
$0.01 P/Share
|
|
Jan 03
2022
|
Michael A Arends Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
59,000
+4.72%
|
$0
$0.01 P/Share
|
|
Jan 03
2022
|
Russell C Horowitz Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
51,000
+5.73%
|
$0
$0.01 P/Share
|
|
Dec 30
2021
|
Michael A Arends Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
98,000
+7.97%
|
$0
$0.01 P/Share
|
|
Dec 30
2021
|
Russell C Horowitz Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
47,500
+5.69%
|
$0
$0.01 P/Share
|
|
Dec 02
2021
|
Dennis Cline |
SELL
Other acquisition or disposition
|
Direct |
50,000
-34.07%
|
-
|
|
Nov 22
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
798,714
+5.7%
|
$1,597,428
$2.5 P/Share
|
|
Nov 10
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,412
+0.18%
|
$44,824
$2.75 P/Share
|
|
Oct 01
2021
|
Donald Cogsville |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+19.84%
|
$0
$0.01 P/Share
|
|
Oct 01
2021
|
Russell C Horowitz Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+1.99%
|
$0
$0.01 P/Share
|
|
Oct 01
2021
|
Dennis Cline |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+9.27%
|
$0
$0.01 P/Share
|
|
Oct 01
2021
|
Manuel W Wisehart |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+4.9%
|
$0
$0.01 P/Share
|
|
Sep 16
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,769
+0.01%
|
$3,538
$2.99 P/Share
|
|
Sep 15
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,676
+0.01%
|
$3,352
$3.0 P/Share
|
|
Sep 14
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
31,451
+0.08%
|
$94,353
$3.02 P/Share
|
|
Sep 13
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
447
+0.0%
|
$1,341
$3.0 P/Share
|
|
Sep 10
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,275
+0.03%
|
$21,825
$3.01 P/Share
|
|
Sep 08
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
7,100
+0.06%
|
$21,300
$3.0 P/Share
|
|
Sep 07
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,554
+0.15%
|
$112,662
$3.05 P/Share
|
|
Aug 27
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
51,428
+0.21%
|
$154,284
$3.07 P/Share
|
|
Aug 25
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
26,065
+0.21%
|
$78,195
$3.05 P/Share
|
|
Aug 20
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,300
+0.04%
|
$10,600
$2.9 P/Share
|
|
Aug 18
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,549
+0.1%
|
$25,098
$2.89 P/Share
|
|
Aug 10
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,473
+0.06%
|
$30,946
$2.9 P/Share
|
|
Aug 09
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,521
+0.05%
|
$13,042
$2.94 P/Share
|
|
Aug 06
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
53,805
+0.15%
|
$107,610
$2.94 P/Share
|
|
Apr 09
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.82%
|
$200,000
$2.8 P/Share
|
|
Mar 31
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,551
+0.15%
|
$35,102
$2.8 P/Share
|
|
Jan 04
2021
|
John Roswech Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+9.72%
|
$0
$0.01 P/Share
|
|
Jan 04
2021
|
Ryan Polley Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+12.12%
|
$0
$0.01 P/Share
|
|
Jan 04
2021
|
Michael A Arends Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
46,000
+4.26%
|
$0
$0.01 P/Share
|
|
Jan 04
2021
|
Russell C Horowitz Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+5.35%
|
$0
$0.01 P/Share
|
|
Dec 31
2020
|
Michael A Arends Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
195,000
+16.48%
|
$0
$0.01 P/Share
|
|
Dec 31
2020
|
Russell C Horowitz Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+12.19%
|
$0
$0.01 P/Share
|
|
Dec 30
2020
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,748
+0.31%
|
$40,748
$1.75 P/Share
|
|
Dec 18
2020
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
250,000
+2.02%
|
$500,000
$2.5 P/Share
|
|
Dec 08
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$250
$2.42 P/Share
|
|
Dec 03
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$250
$2.15 P/Share
|
|
Dec 01
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$250
$2.18 P/Share
|
|
Nov 24
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$250
$2.06 P/Share
|
|
Nov 19
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$125
$1.84 P/Share
|
|
Nov 17
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$125
$1.86 P/Share
|
|
Nov 12
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$125
$1.79 P/Share
|
|
Nov 10
2020
|
Michael A Arends Vice Chairman |
BUY
Open market or private purchase
|
Direct |
125
+0.02%
|
$125
$1.81 P/Share
|
|
Oct 22
2020
|
Dennis Cline |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+10.22%
|
$0
$0.01 P/Share
|